<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36250103</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Follow-up of young adult monozygotic twins after simultaneous critical coronavirus disease 2019: A case report.</ArticleTitle><Pagination><StartPage>1008585</StartPage><MedlinePgn>1008585</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1008585</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.1008585</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The influence of the host genome on coronavirus disease 2019 (COVID-19) susceptibility and severity is supported by reports on monozygotic (MZ) twins where both were infected simultaneously with similar disease outcomes, including several who died due to the SARS-CoV-2 infection within days apart. However, successive exposures to pathogens throughout life along with other environmental factors make the immune response unique for each individual, even among MZ twins.</AbstractText><AbstractText Label="CASE PRESENTATION AND METHODS" NlmCategory="UNASSIGNED">Here we report a case of a young adult monozygotic twin pair, who caught attention since both presented simultaneously severe COVID-19 with the need for oxygen support despite age and good health conditions. One of the twins, who spent more time hospitalized, reported symptoms of long-COVID even 7 months after infection. Immune cell profile and specific responses to SARS-CoV-2 were evaluated as well as whole exome sequencing.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Although the MZ twin brothers shared the same genetic mutations which may be associated with their increased risk of developing severe COVID-19, their clinical progression was different, reinforcing the role of both immune response and genetics in the COVID-19 presentation and course. Besides, post-COVID syndrome was observed in one of them, corroborating an association between the duration of hospitalization and the occurrence of long-COVID symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 de Castro, Silva, Soares, C&#xf3;ria, Naslavsky, Scliar, Castelli, de Oliveira, Sasahara, Santos, Cunha-Neto, Kalil and Zatz.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Castro</LastName><ForeName>Mateus V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Monize V R</ForeName><Initials>MVR</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Fl&#xe1;via B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Evolutionary Biology, Biosciences Institute, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xf3;ria</LastName><ForeName>Vivian R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naslavsky</LastName><ForeName>Michel S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Evolutionary Biology, Biosciences Institute, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scliar</LastName><ForeName>Marilia O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Evolutionary Biology, Biosciences Institute, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelli</LastName><ForeName>Erick C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Molecular Genetics and Bioinformatics Laboratory, Experimental Research Unit (Unipex), School of Medicine, S&#xe3;o Paulo State University (UNESP), Botucatu, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Jamile R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Disciplina de Alergia e Imunologia Cl&#xed;nica, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o (InCor), LIM 19, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasahara</LastName><ForeName>Greyce L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o (InCor), LIM 19, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Keity S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Disciplina de Alergia e Imunologia Cl&#xed;nica, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o (InCor), LIM 19, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia-Instituto Nacional de Ci&#xea;ncias e Tecnologia-iii-INCT, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha-Neto</LastName><ForeName>Edecio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Disciplina de Alergia e Imunologia Cl&#xed;nica, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o (InCor), LIM 19, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia-Instituto Nacional de Ci&#xea;ncias e Tecnologia-iii-INCT, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalil</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Disciplina de Alergia e Imunologia Cl&#xed;nica, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o (InCor), LIM 19, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia-Instituto Nacional de Ci&#xea;ncias e Tecnologia-iii-INCT, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zatz</LastName><ForeName>Mayana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human Genome and Stem Cell Research Center, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Evolutionary Biology, Biosciences Institute, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Med (Lausanne). 2023 Apr 28;10:1185833. doi: 10.3389/fmed.2023.1185833</RefSource><PMID Version="1">37188090</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">genetic variants</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">monozygotic twins</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36250103</ArticleId><ArticleId IdType="pmc">PMC9558815</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.1008585</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. Geneva: World Health Organization; (2022).</Citation></Reference><Reference><Citation>Fricke-Galindo I, Falf&#xe1;n-Valencia R. Genetics insight for COVID-19 susceptibility and severity: A review. Front Immunol. (2021) 12:622176. 10.3389/fimmu.2021.622176</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.622176</ArticleId><ArticleId IdType="pmc">PMC8047200</ArticleId><ArticleId IdType="pubmed">33868239</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan TP, Pallerla SR, R&#xfc;ter J, Augustin Y, Kremsner PG, Krishna S, et al. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine. (2021) 72:103629. 10.1016/j.ebiom.2021.103629</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103629</ArticleId><ArticleId IdType="pmc">PMC8512556</ArticleId><ArticleId IdType="pubmed">34655949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. (2020) 370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. (2020) 370:eabd4570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgari S, Pousaz LA. Human genetic variants identified that affect COVID susceptibility and severity. Nature. (2021) 600:390&#x2013;1. 10.1038/d41586-021-01773-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01773-7</ArticleId><ArticleId IdType="pubmed">34239107</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Mehrtak M, MohsseniPour M, Mirzapour P, Barzegary A, Habibi P, et al. Genetic susceptibility of COVID-19: A systematic review of current evidence. Eur J Med Res. (2021) 26:46. 10.1186/s40001-021-00516-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00516-8</ArticleId><ArticleId IdType="pmc">PMC8135169</ArticleId><ArticleId IdType="pubmed">34016183</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JL, Su HC. COVID human genetic effort. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. (2020) 181:1194&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218368</ArticleId><ArticleId IdType="pubmed">32405102</ArticleId></ArticleIdList></Reference><Reference><Citation>Povysil G, Butler-Laporte G, Shang N, Wang C, Khan A, Alaamery M, et al. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. J Clin Invest. (2021) 131:147834. 10.1172/JCI152475</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152475</ArticleId><ArticleId IdType="pmc">PMC8279578</ArticleId><ArticleId IdType="pubmed">34043590</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. (2020) 324:663&#x2013;73. 10.1001/jama.2020.13719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13719</ArticleId><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene. (2022) 808:145963. 10.1016/j.gene.2021.145963</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2021.145963</ArticleId><ArticleId IdType="pmc">PMC8437745</ArticleId><ArticleId IdType="pubmed">34530086</ArticleId></ArticleIdList></Reference><Reference><Citation>Monticelli M, Hay Mele B, Benetti E, Fallerini C, Baldassarri M, Furini S, et al. Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women. Genes. (2021) 12:596. 10.3390/genes12040596</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12040596</ArticleId><ArticleId IdType="pmc">PMC8073081</ArticleId><ArticleId IdType="pubmed">33921689</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulle I, Vicentini C, Clerici M, Biasin M. Antigen presentation in SARS-CoV-2 infection: The role of class I HLA and ERAP polymorphisms. Hum Immunol. (2021) 82:551&#x2013;60. 10.1016/j.humimm.2021.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2021.05.003</ArticleId><ArticleId IdType="pmc">PMC8108382</ArticleId><ArticleId IdType="pubmed">34116863</ArticleId></ArticleIdList></Reference><Reference><Citation>Setaro AC, Gaglia MM. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. Curr Res Virol Sci. (2021) 2:100015. 10.1016/j.crviro.2021.100015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crviro.2021.100015</ArticleId><ArticleId IdType="pmc">PMC8588586</ArticleId><ArticleId IdType="pubmed">34786565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokuina E, Breff-Fonseca MC, Villegas-Valverde CA, Mora-D&#xed;az I. Normal values of T, B and NK lymphocyte subpopulations in peripheral blood of healthy cuban adults. MEDICC Rev. (2019) 21:16&#x2013;21. 10.37757/MR2019.V21.N2-3.5</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/MR2019.V21.N2-3.5</ArticleId><ArticleId IdType="pubmed">31373580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. (2022) 603:587&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, P&#xe4;&#xe4;bo S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature. (2020) 587:610&#x2013;2. 10.1038/s41586-020-2818-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2818-3</ArticleId><ArticleId IdType="pubmed">32998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli EC, Paz MA, Souza AS, Ramalho J, Mendes-Junior CT. Hla-mapper: An application to optimize the mapping of HLA sequences produced by massively parallel sequencing procedures. Hum Immunol. (2018) 1:678. 10.1016/j.humimm.2018.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2018.06.010</ArticleId><ArticleId IdType="pubmed">30122171</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 Gwas Group Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, et al. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. (2020) 383:1522&#x2013;34. 10.1056/NEJMoa2020283</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsucci D, Trezzi M, Anichini R, Blanc P, Barontini L, Biagini C, et al. Increased creatine kinase may predict a worse COVID-19 outcome. J Clin Med. (2021) 10:1734. 10.3390/jcm10081734</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081734</ArticleId><ArticleId IdType="pmc">PMC8073399</ArticleId><ArticleId IdType="pubmed">33923719</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ke Y, Xia X, Wang Y, Cheng F, Liu X, et al. Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov. (2021) 7:1&#x2013;16. 10.1038/s41421-021-00318-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00318-6</ArticleId><ArticleId IdType="pmc">PMC8408196</ArticleId><ArticleId IdType="pubmed">34465742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: An ACE2 and TMPRSS2 polymorphism analysis. BMC Med. (2020) 18:216. 10.1186/s12916-020-01673-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01673-z</ArticleId><ArticleId IdType="pmc">PMC7360473</ArticleId><ArticleId IdType="pubmed">32664879</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli EC, de Castro MV, Naslavsky MS, Scliar MO, Silva NSB, Andrade HS, et al. MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals. Front Immunol. (2021) 12:3898. 10.3389/fimmu.2021.742881</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742881</ArticleId><ArticleId IdType="pmc">PMC8506217</ArticleId><ArticleId IdType="pubmed">34650566</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literature. Medicine. (2016) 95:e5081. 10.1097/MD.0000000000005081</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005081</ArticleId><ArticleId IdType="pmc">PMC5059085</ArticleId><ArticleId IdType="pubmed">27749582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Rawlings DJ, Witte ON. Role of Bruton&#x2019;s tyrosine kinase in immunodeficiency. Curr Opin Immunol. (1994) 6:623&#x2013;30. 10.1016/0952-7915(94)90151-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-7915(94)90151-1</ArticleId><ArticleId IdType="pubmed">7946052</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruda LCM, Gaballa A, Da Silva Rodrigues R, Makower B, Uhlin M. SARS-CoV-2 (COVID-19)-specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observation. Scand J Immunol. (2022) 95:e13151. 10.1111/sji.13151</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.13151</ArticleId><ArticleId IdType="pmc">PMC9115348</ArticleId><ArticleId IdType="pubmed">35212005</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. (2020) 53:442.e&#x2013;55.e. 10.1016/j.immuni.2020.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Cabezas B, Ribeiro R, Costa I, Esteves S, Teixeira AR, Reis T, et al. IL-2 and IFN-&#x3b3; are biomarkers of SARS-CoV-2 specific cellular response in whole blood stimulation assays. medRxiv [Preprint] (2021). 10.1101/2021.01.04.20248897</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.04.20248897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal K, Kaur H, Sarma P, Bhattacharyya A, Sharma DJ, Prajapat M, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. (2022) 67:172&#x2013;81. 10.1016/j.jcrc.2021.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.09.023</ArticleId><ArticleId IdType="pmc">PMC8604557</ArticleId><ArticleId IdType="pubmed">34808527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>